Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Experimental Organism Basal Cell Carcinoma
0.070 GeneticVariation phenotype BEFREE A weak association between XPD exon 6 silent C/A polymorphism and BCC development risk was found when comparing single polymorphisms between the two groups. 25209577 2014
Experimental Organism Basal Cell Carcinoma
0.070 GeneticVariation phenotype BEFREE We interpret these data as showing that XPD SNP mediate susceptibility to BCC. 15776433 2005
Experimental Organism Basal Cell Carcinoma
0.070 Biomarker phenotype BEFREE While it cannot be ruled out that the present findings are due to chance, the present results are consistent with previous findings that XPD Arg156Arg is a weak risk factor for basal cell carcinoma. 15936590 2005
Experimental Organism Basal Cell Carcinoma
0.070 GeneticVariation phenotype BEFREE The results show a significant association between BCC and the A-allele of a polymorphism in ERCCI exon4 (Odds ratio 12;95% Confidence Interval 1.17-124; p(chi2, two-side) = 0.019) and to a lesser extent with XPD exon6 (p = 0.06). 12645871 2003
Experimental Organism Basal Cell Carcinoma
0.070 GeneticVariation phenotype BEFREE In this paper, we present evidence that alleles of several polymorphisms in the chromosomal region 19q13.2-3, encompassing the genes RAI and XPD, are associated with occurrence of basal cell carcinoma in Caucasian Americans. 12433725 2002
Experimental Organism Basal Cell Carcinoma
0.070 GeneticVariation phenotype BEFREE Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. 11375896 2001
Experimental Organism Basal Cell Carcinoma
0.070 GeneticVariation phenotype BEFREE We have studied the role of two nucleotide substitutions in the XPD gene, one in exon 23 leading to an amino acid substitution (Lys751Gln) and one silent in exon 6 in relation to basal cell carcinoma (BCC). 9950243 1999